Intensive Management Program Benefits High-Risk Patients

Share this content:
Intensive Management Program Benefits High-Risk Patients
Intensive Management Program Benefits High-Risk Patients

MONDAY, July 2, 2018 (HealthDay News) -- For high-risk patients, use of an intensive management program is associated with greater receipt of outpatient care with no increase in total costs, according to a study published in the June 19 issue of the Annals of Internal Medicine.

Jean Yoon, Ph.D., from the U.S. Department of Veterans Affairs in Menlo Park, California, and colleagues examined whether augmenting usual primary care with team-based intensive management reduces utilization and costs for high-risk patients in five U.S. Department of Veterans Affairs medical centers. A total of 2,210 patients with an average of seven chronic conditions were randomized to intensive management and usual care (1,105 patients to each).

The researchers found that 44 percent of the patients assigned to intensive management received intensive outpatient care, with three or more encounters in person or by telephone, and 18 percent received limited intervention. The mean inpatient costs decreased more for the intensive management than the usual care group from the pre- to post-randomization periods (−$2,164). Compared with the usual care group, outpatient costs increased more for the intensive management group ($2,636), which was driven by more use of primary care, home care, telephone care, and telehealth. Before and after randomization, the mean total costs were similar in the two groups.

"High-risk patients with access to an intensive management program received more outpatient care with no increase in total costs," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

8 More U.S. Communities to Be Assessed for PFAS Toxin Exposure

8 More U.S. Communities to Be Assessed for ...

Assessments will lay groundwork for future study of the health effects of perfluoroalkyl, polyfluoroalkyl

FDA Advances Regulation to Ensure Sunscreen Safety, Efficacy

FDA Advances Regulation to Ensure Sunscreen Safety, Efficacy

Proposed rule will help consumers better understand what the sunscreens they are buying can actually do

U.S. Agencies Probing Johnson  Johnson Over Asbestos in Talc

U.S. Agencies Probing Johnson & Johnson Over Asbestos ...

Company has faced lawsuits linking its body powders with ovarian cancer or mesothelioma

is free, fast, and customized just for you!




Already a member?

Sign In Now »